Medicamen Biotech Ltd. Live Share Price Today, Share Analysis and Chart

Name: Medicamen Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Medicamen Biotech Ltd.
Rating: 1.886208375
Author: Trendlyne DVM scores

Expensive Underperformer

about

Medicamen Biotech is engaged in manufacturing of Finished Dosage Forms (FDF).

405.15 21.10 (5.49%)

35.69% Fall from 52W High

74,163

NSE+BSE Volume

High volume+gain today

NSE 16 Jul, 2025 3:53 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

45.0 / 100

Expensive Valuation

29.7 / 100

Technically Bearish

31.2 / 100

Expensive Underperformer These stocks are medium in financial scores. They have bad valuation and technical scores as well. View Similar Embed DVM

No estimates available

Medicamen Biotech Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%

Medicamen Biotech Ltd. Live Share Price Today, Share Analysis and Chart

Medicamen Biotech is engaged in manufacturing of Finished Dosage Forms (FDF).

35.69% Fall from 52W High

High volume+gain today

SWOT Analysis

Medicamen Biotech Live Price Chart